Navigation Links
Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
Date:6/2/2008

he factors discussed under the caption "Risk Factors" in Genzyme's Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. We caution investors not to place undue reliance on the forward-looking statements contained in this press release. These statements speak only as of the date of this press release, and we undertake no obligation to update or revise the statements.

Genzyme(R) and Clolar(R) are registered trademarks of Genzyme Corporation. All rights reserved.

Genzyme's press releases and other company information are available at http://www.genzyme.com and by calling Genzyme's investor information line at 1-800-905-4369 within the United States or 1-678-999-4572 outside the United States.

Media Contact: Investor Contact:

Maria Cantor Catherine Forte

(617) 768-6690 (617) 768-6881


'/>"/>
SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
3. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
4. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
5. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
8. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
9. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
10. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
11. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
(Date:5/22/2013)... and CAESAREA, Israel , May 22, ... New clinical data presented from the DEFLECT-I study demonstrates ... reduces brain lesion volume during TAVR (Transcatheter Aortic Valve ... Keystone Heart Scientific Advisory Board announces consensus on the ... regarding the importance and need for cerebral protection during ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
(Date:5/23/2013)... Heights,OH (PRWEB) May 23, 2013 Angeline Jolie’s ... genetic study showing there was an 87% chance she would ... odds of getting breast cancer. Long term studies show American ... during their lifetime (1). , Among the things that ... alcohol (more than a drink a day) smoking, and avoiding ...
(Date:5/23/2013)... According to the Centers for Disease Control, heart ... America today and is the leading cause of death in ... in the United States each year of heart disease, translating ... to profile the status of the cardiovascular system, with cholesterol ... the false assumption that if cholesterol levels are good, this ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 US ... 5.1 percent annually to $8.0 billion in 2017. ... the increasing need for high-performance plastic films that ... and chemical resistance in packaging and construction applications. ... market areas such as photovoltaic modules biodegradable products, ...
(Date:5/23/2013)... 23, 2013 Dr. Garber's Natural ... specific remedies are now available at Whole Foods Laguna ... 92677. The line of natural biotherapy formulas continues to ... , Represented by Brandstorm HBC (Los Angeles, CA), the ... throughout California, Nevada and Arizona, as well as Lassen's ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Spring is ... Assisi Veterinary Hospital urges pet owners to be aware of ... treatments for pet allergies. , An allergy is a state ... called an allergen. Allergen exposure may cause an over-reaction. This ... against infection and disease, can actually be harmful to the ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie has Women Asking for Ways to Reduce the Risk of Breast Cancer 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 3Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 2Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 3Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 4Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Allergy Season Affects Pets as Well as People 2
... sympathetic to people suffering from the same misfortune as a ... generally more sympathetic, according to the authors of a new ... A. Small and Uri Simonsohn (both University of Pennsylvania) seek ... become more sympathetic when a friend or loved one falls ...
... into the desire to have an attractive smile is ... immigrants are the most receptive to oral health messages, ... of Consumer Research . , Authors Shuili Du ... and C.B. Bhattacharya (Boston University) evaluated the effectiveness of ...
... The American Academy of Actuaries, Public Interest Committee ... market value of assets and liabilities for ... use information obtained through this forum ... board of directors on the issue is appropriately in the public ...
... 22 Republican National,Committee (RNC) Chairman Robert M. ... http://www.newscom.com/cgi-bin/prnh/20080519/RNCLOGO ), "While Barack Obama ... political tactics to push poor people away from ... is yet another example of,Obama,s rhetoric not matching ...
... --, NEW YORK, Aug. 22 The Guardian ... has hired industry veteran,Dale Magner to its leadership team. ... plan sales and distribution to his new post as,Vice ... August 12., Magner will be responsible for developing ...
... ST. LOUIS, Aug. 22 CMS, Inc., an ... and workflow management,solutions, has received FDA 510(k) clearance ... allows CMS to immediately,begin distributing Atlas-Based Autosegmentation for ... the amount of time spent creating and editing,patient ...
Cached Medicine News:Health News:Charities take note: Personal relationships increase donations 2Health News:A reason to smile: New immigrants respond best to oral hygiene campaign 2Health News:Actuaries to Host Forum on Public Pension Disclosures 2Health News:Actuaries to Host Forum on Public Pension Disclosures 3Health News:RNC Statement Obama and Health Care 2Health News:Dale Magner Joins Guardian as Vice President 2Health News:CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: